Multiparametric Prostate MRI Protocol
Perform multiparametric prostate MRI using a 3-Tesla scanner (or minimum 1.5T) with T2-weighted imaging, diffusion-weighted imaging (DWI) with ADC maps, and dynamic contrast-enhanced (DCE) sequences, interpreting findings according to PI-RADS v2.1 scoring system. 1
Scanner Specifications and Technical Requirements
Use a 3-Tesla MRI scanner as the optimal field strength, though 1.5T is acceptable if 3T is unavailable. The higher field strength provides superior signal-to-noise ratio and image resolution critical for detecting clinically significant prostate cancer 2, 3.
Employ a pelvic phased-array coil for signal reception. While endorectal coils can enhance image quality at 1.5T, they are not mandatory at 3T and add patient discomfort 2.
Required Imaging Sequences
The standard mpMRI protocol consists of three essential components 1, 4:
1. T2-Weighted Imaging (Morphological Sequence)
- Primary determinant for transition zone lesion assessment
- Provides anatomical detail and zonal differentiation
- Essential for measuring prostate volume 5
2. Diffusion-Weighted Imaging with ADC Maps (Functional Sequence)
- Primary determinant for peripheral zone lesion assessment
- Most critical sequence for cancer detection in peripheral zone
- Detects lesions ≥0.5 mL volume for Gleason 3+3, and ≥0.2 mL for Gleason ≥3+4 patterns 1
3. Dynamic Contrast-Enhanced MRI (DCE-MRI)
- Secondary/clarification role only for peripheral zone PI-RADS 3 lesions
- Relegated to minor role in PI-RADS v2 compared to earlier versions
- Uses qualitative assessment (presence/absence of focal enhancement) 1, 6
Note: PI-RADS v2 specifically eliminated spectroscopic imaging from the protocol 1.
Gadolinium Contrast Administration
Administer gadolinium-based contrast agent at 0.1 mmol/kg IV for the DCE sequence 7.
Critical Safety Considerations:
- Screen for renal impairment before contrast administration—gadolinium increases risk of nephrogenic systemic fibrosis (NSF) in patients with impaired renal function 7
- In patients with severe renal impairment, consider prompt hemodialysis post-administration (72% removed after first dialysis) 7
- Protect from light and store at room temperature; do not freeze 7
PI-RADS v2.1 Interpretation System
The PI-RADS assessment uses a 5-point categorical scale indicating likelihood of clinically significant prostate cancer 1:
- PI-RADS 1-2: Low likelihood (but does not completely exclude cancer)
- PI-RADS 3: Intermediate/equivocal
- PI-RADS 4: High likelihood
- PI-RADS 5: Very high likelihood (not proof, but highly likely)
Zone-Specific Interpretation Algorithm:
Peripheral Zone Lesions:
- DWI is the dominant/primary sequence
- DCE-MRI serves only to upgrade PI-RADS 3 lesions to PI-RADS 4 if positive
- T2-weighted provides secondary information 1, 6
Transition Zone Lesions:
- T2-weighted imaging is the dominant/primary sequence
- DWI provides secondary classification
- DCE-MRI has minimal role 1, 4
Reporting Requirements:
Report up to 4 most suspicious lesions of category 3-5, documenting 1, 5:
- PI-RADS category for each lesion
- Location using sector map
- Index lesion identification (largest/highest grade)
- Two-dimensional measurement on axial T2-weighted imaging (minimum standard)
- Radiological T-stage
- Prostate volume
Clinical Context and Limitations
Key Understanding: PI-RADS does not aim to detect all prostate cancers—it deliberately has lower sensitivity for low-volume Gleason 3+3 disease (<0.5 mL) that is unlikely to cause patient harm 1. This addresses overdiagnosis concerns while maintaining high detection rates for clinically significant cancer.
Critical Pitfall: PI-RADS v2 is an imaging-only system and does not incorporate clinical factors (PSA, PSA density, family history, DRE findings) into the assessment categories. These clinical factors must be integrated separately for management decisions 1.
The system performs best when high-quality imaging, standardized reporting, and MR-directed biopsies are performed by radiologists and urologists working in multidisciplinary teams 1.
Quality Assurance
Ensure protocol compliance with PI-RADS technical specifications to minimize interpretation variability 1, 8. Non-index lesions are frequently missed even when high-grade, and lesion size is often underestimated on mpMRI 1. Larger, higher-grade lesions with non-cribriform patterns are most reliably detected 1.